Wiseman SM - Search Results

1

MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.

Kasaian K, Chindris AM, Wiseman SM, Mungall KL, Zeng T, Tse K, Schein JE, Rivera M, Necela BM, Kachergus JM, Casler JD, Mungall AJ, Moore RA, Marra MA, Copland JA, Thompson EA, Smallridge RC, Jones SJ. Kasaian K, et al. Among authors: wiseman sm. J Clin Endocrinol Metab. 2015 Apr;100(4):E611-5. doi: 10.1210/jc.2014-3622. Epub 2015 Jan 27. J Clin Endocrinol Metab. 2015. PMID: 25625803 Free PMC article.

2

Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.

Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Filipenko D, Huntsman D, Gilks B. Wiseman SM, et al. Am J Surg. 2006 May;191(5):581-7. doi: 10.1016/j.amjsurg.2006.02.005. Am J Surg. 2006. PMID: 16647341

3

Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.

Griffith OL, Melck A, Jones SJ, Wiseman SM. Griffith OL, et al. Among authors: wiseman sm. J Clin Oncol. 2006 Nov 1;24(31):5043-51. doi: 10.1200/JCO.2006.06.7330. J Clin Oncol. 2006. PMID: 17075124 Review.

4

Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma.

Wiseman SM, Griffith OL, Deen S, Rajput A, Masoudi H, Gilks B, Goldstein L, Gown A, Jones SJ. Wiseman SM, et al. Arch Surg. 2007 Aug;142(8):717-27; discussion 727-9. doi: 10.1001/archsurg.142.8.717. Arch Surg. 2007. PMID: 17709725

5

Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.

Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM. Melck A, et al. Among authors: wiseman sm. Ann Surg Oncol. 2007 Dec;14(12):3403-11. doi: 10.1245/s10434-007-9572-8. Epub 2007 Sep 20. Ann Surg Oncol. 2007. PMID: 17882495

6

Clinical utility of type 1 growth factor receptor expression in colon cancer.

Leung SP, Griffith OL, Masoudi H, Gown A, Jones S, Phang T, Wiseman SM. Leung SP, et al. Among authors: wiseman sm. Am J Surg. 2008 May;195(5):604-10. doi: 10.1016/j.amjsurg.2007.12.032. Am J Surg. 2008. PMID: 18424279

7

Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.

Wiseman SM, Griffith OL, Melck A, Masoudi H, Gown A, Nabi IR, Jones SJ. Wiseman SM, et al. Am J Surg. 2008 May;195(5):667-73; discussion 673. doi: 10.1016/j.amjsurg.2008.01.008. Am J Surg. 2008. PMID: 18424286

8

Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.

Wiseman SM, Melck A, Masoudi H, Ghaidi F, Goldstein L, Gown A, Jones SJ, Griffith OL. Wiseman SM, et al. Ann Surg Oncol. 2008 Oct;15(10):2811-26. doi: 10.1245/s10434-008-0034-8. Epub 2008 Jul 9. Ann Surg Oncol. 2008. PMID: 18612701

9

Biomarker panel diagnosis of thyroid cancer: a critical review.

Griffith OL, Chiu CG, Gown AM, Jones SJ, Wiseman SM. Griffith OL, et al. Among authors: wiseman sm. Expert Rev Anticancer Ther. 2008 Sep;8(9):1399-413. doi: 10.1586/14737140.8.9.1399. Expert Rev Anticancer Ther. 2008. PMID: 18759692 Review.

10

Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.

Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H, Leung S, Wiseman SM, Nabi IR. Joshi B, et al. Among authors: wiseman sm. Cancer Res. 2008 Oct 15;68(20):8210-20. doi: 10.1158/0008-5472.CAN-08-0343. Cancer Res. 2008. PMID: 18922892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters